- AstraZeneca to withdraw Covid vaccine worldwide, citing a drop in demandon May 8, 2024 at 5:50 pm
Pharmaceutical giant AstraZeneca on Wednesday said it planned to withdraw its Covid-19 vaccine as demand for it has declined.
- Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supplyon May 8, 2024 at 3:39 pm
Eli Lilly and Novo Nordisk are boosting supply of their weight loss drugs, while Apple Watch's heart-monitoring tech was approved for use in clinical studies.
- Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance on May 7, 2024 at 7:48 pm
Amgen, Viking Therapeutics, Altimmune, AstraZeneca, Boehringer Ingelheim and Zealand Pharma are progressing on their own treatments.
- Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slideon May 3, 2024 at 5:43 pm
Amgen's update fueled concerns about potential new competition in the weight loss drug market, sending shares of Novo Nordisk and Eli Lilly lower.
- Amgen scraps experimental weight loss pill, moves forward with injectionon May 2, 2024 at 10:59 pm
Amgen is among several drugmakers racing to join the red-hot weight loss drug space dominated by Novo Nordisk and Eli Lilly.
- Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take holdon May 2, 2024 at 8:00 pm
The company reiterated its full-year 2024 sales guidance of roughly $4 billion, which includes revenue from the expected launch of its RSV vaccine.
- UnitedHealth CEO estimates one-third of Americans could be impacted by Change Healthcare cyberattackon May 1, 2024 at 9:01 pm
UnitedHealth CEO estimates that data from one-third of Americans could have been compromised in the Change Healthcare cyberattack.
- UnitedHealth CEO tells lawmakers the company paid hackers a $22 million ransomon May 1, 2024 at 8:41 pm
Senators questioned UnitedHealth Group CEO Andrew Witty on Wednesday about a cyberattack on its subsidiary Change Healthcare.
- Johnson & Johnson to pay $6.5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S.on May 1, 2024 at 8:23 pm
The deal would allow J&J to resolve the lawsuits through a third bankruptcy filing of a subsidiary company, LTL Management.
- CVS shares plummet as health company slashes profit outlook on higher medical costson May 1, 2024 at 8:19 pm
CVS and other insurers have seen medical costs spike as many Medicare Advantage patients return to hospitals to undergo procedures they delayed during Covid.